What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Statistics
- Surgery
John E. Connett spends much of his time researching Internal medicine, Physical therapy, Smoking cessation, Randomized controlled trial and COPD.
His Internal medicine course of study focuses on Cardiology and Inhaler.
His study in Physical therapy is interdisciplinary in nature, drawing from both Prospective cohort study, Clinical trial and Risk factor.
As part of the same scientific family, John E. Connett usually focuses on Clinical trial, concentrating on Spirometry and intersecting with FEV1/FVC ratio.
His Smoking cessation research includes elements of Ipratropium bromide, Lung cancer, Gerontology and Airway obstruction.
His research integrates issues of Gastric bypass surgery, Epidemiology and Type 2 diabetes in his study of Randomized controlled trial.
His most cited work include:
- Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1: The Lung Health Study (1646 citations)
- The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. (961 citations)
- Azithromycin for Prevention of Exacerbations of COPD (806 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, COPD, Randomized controlled trial, Physical therapy and Smoking cessation.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Cardiology.
His research in COPD intersects with topics in Proportional hazards model, Exacerbation, Immunology and Lung.
His research investigates the connection between Randomized controlled trial and topics such as Clinical trial that intersect with problems in Lung health.
In his study, Cohort is strongly linked to Prospective cohort study, which falls under the umbrella field of Physical therapy.
His biological study spans a wide range of topics, including Respiratory disease, Methacholine, Cotinine and Abstinence.
He most often published in these fields:
- Internal medicine (38.03%)
- COPD (30.05%)
- Randomized controlled trial (19.25%)
What were the highlights of his more recent work (between 2014-2020)?
- Internal medicine (38.03%)
- COPD (30.05%)
- Randomized controlled trial (19.25%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, COPD, Randomized controlled trial, Exacerbation and Cohort.
His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Cardiology.
His studies in COPD integrate themes in fields like Immunology, Intensive care medicine, Proportional hazards model, Hazard ratio and Spirometry.
His studies deal with areas such as Pediatrics and Type 2 diabetes as well as Randomized controlled trial.
The Exacerbation study combines topics in areas such as Emergency department and Logistic regression.
His Cohort research integrates issues from Clinical trial, Graft survival, Creatinine, Prospective cohort study and Atrophy.
Between 2014 and 2020, his most popular works were:
- Coronary Artery Disease in Patients With Out-of-Hospital Refractory Ventricular Fibrillation Cardiac Arrest (138 citations)
- Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study. (111 citations)
- Health Coaching and Chronic Obstructive Pulmonary Disease Rehospitalization. A Randomized Study (82 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Statistics
- Surgery
John E. Connett focuses on Internal medicine, COPD, Randomized controlled trial, Pediatrics and Type 2 diabetes.
His work in Internal medicine is not limited to one particular discipline; it also encompasses Cardiology.
His COPD research is multidisciplinary, incorporating perspectives in Clinical trial, Quality of life, Polypharmacy, Intensive care medicine and Spirometry.
John E. Connett has researched Clinical trial in several fields, including Linear regression, Lung, Regression analysis, Lung cancer and Statistic.
His work in Type 2 diabetes covers topics such as Roux-en-Y anastomosis which are related to areas like Surgery and Gastroenterology.
His studies examine the connections between Physical therapy and genetics, as well as such issues in FEV1/FVC ratio, with regards to Pulmonary function testing and Airway obstruction.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
